Cardiovascular Surgery and Interventions 2021, Vol 8, Num 1 Page(s): 008-012
Aortofemoral bypass in occlusive TASC-C and TASC-D lesions: Midterm results of 28 cases

Ekin İlkeli1, Ali Cemal Düzgün2

1Department of Cardiovascular Surgery, Düzce State Hospital, Düzce, Turkey
2Department of Cardiovascular Surgery, Ankara Training and Research Hospital, Ankara, Turkey

Keywords: Aortoiliac occlusive disease, bypass grafting, cardiovascular diseases, vascular prosthesis
Objectives: This study aims to evaluate the three-year patency rates of aortofemoral bypass surgery in the clinical and radiological diagnosis of Trans-Atlantic Inter-Society Consensus (TASC)-C and TASC-D aortoiliac lesions.

Patients and methods: Medical records of a total of 28 patients (21 males, 7 females; mean age: 64.8±8.6 years; range, 58 to 72 years) with TASC-C and TASC-D aortoiliac lesions who underwent aortofemoral bypass surgery between September 2014 and December 2018 were retrospectively analyzed. Demographic and clinical characteristics of the patients were recorded. All operations were performed by a single surgical team by placing a Y graft in the anatomical location and using open median laparotomy technique. The Y graft bypass results with peri- and postoperative data were evaluated.

Results: Dacron Y grafts were used in 18 of TASC-C (25%) and TASC-D (75%) lesions, and polytetrafluoroethylene Y grafts were used in 10 of them. No reoperation or amputation was performed in any patient during follow-up. The mean patency of vascular Y grafts was 92% after three years. There was no significant difference between the graft types and postoperative patient values (p>0.05). Mortality was observed in one patient due to systemic inflammatory response syndrome.

Conclusion: The patency of vascular grafts for aortoiliac occlusive disease is satisfactory in TASC-C and D lesions.

DOI : 10.5606/e-cvsi.2021.1010